Multiple MicroRNAs Within the 14q32 Cluster Target the MRNAs of Major Type 1 Diabetes Autoantigens IA-2, IA-2β, and GAD65

Overview

Journal FASEB J

Specialties Biology
Physiology

Date 2015 Jul 8

PMID 26148972

Citations 17

Authors

Liron Abuhatzira

Huanyu Xu

Georges Tahhan

Afroditi Boulougoura

Alejandro A Schaffer

Abner L Notkins

Affiliations

Soon will be listed here.

Abstract

Islet antigen (IA)-2, IA-2β, and glutamate decarboxylase (GAD65) are major autoantigens in type 1 diabetes (T1D). Autoantibodies to these autoantigens appear years before disease onset and are widely used as predictive markers. Little is known, however, about what regulates the expression of these autoantigens. The present experiments were initiated to test the hypothesis that microRNAs (miRNAs) can target and affect the levels of these autoantigens. Bioinformatics was used to identify miRNAs predicted to target the mRNAs coding IA-2, IA-2β, and GAD65. RNA interference for the miRNA processing enzyme Dicer1 and individual miRNA mimics and inhibitors were used to confirm the effect in mouse islets and MIN6 cells. We show that the imprinted 14q32 miRNA cluster contains 56 miRNAs, 32 of which are predicted to target the mRNAs of T1D autoantigens and 12 of which are glucose-sensitive. Using miRNA mimics and inhibitors, we confirmed that at least 7 of these miRNAs modulate the mRNA levels of the T1D autoantigens. Dicer1 knockdown significantly reduced the mRNA levels of all 3 autoantigens, further confirming the importance of miRNAs in this regulation. We conclude that miRNAs are involved in regulating the expression of the major T1D autoantigens.

Citing Articles

A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of individuals with recent-onset type 1 diabetes.

Sebastiani G, Grieco G, Bruttini M, Auddino S, Mori A, Toniolli M Cell Rep Med. 2024; 5(6):101591.

PMID: 38838677 PMC: 11228666. DOI: 10.1016/j.xcrm.2024.101591.

Altered Expression of Vitamin D Metabolism Genes and Circulating MicroRNAs in PBMCs of Patients with Type 1 Diabetes: Their Association with Vitamin D Status and Ongoing Islet Autoimmunity.

Al-Nakhle H, Mohsen I, Elnaem B, Alharbi A, Alnakhli I, Almoarfi S Noncoding RNA. 2023; 9(5).

PMID: 37888206 PMC: 10609170. DOI: 10.3390/ncrna9050060.

Hereditable variants of classical protein tyrosine phosphatase genes: Will they prove innocent or guilty?.

Hendriks W, van Cruchten R, Pulido R Front Cell Dev Biol. 2023; 10:1051311.

PMID: 36755664 PMC: 9900141. DOI: 10.3389/fcell.2022.1051311.

Global miRNA expression reveals novel nuclear and mitochondrial interactions in Type 1 diabetes mellitus.

Ferraz R, Santos L, da-Silva-Cruz R, Braga-da-Silva C, Magalhaes L, Ribeiro-Dos-Santos A Front Endocrinol (Lausanne). 2022; 13:1033809.

PMID: 36506063 PMC: 9731375. DOI: 10.3389/fendo.2022.1033809.

Genetic Indices Relationship to Hyperglycemia-associated Biomarkers: Consistency with miRNA Expression in Egyptian Children with T1DM.

Barseem N, Mahasab M, Zaed I, Said A, Masoud Abd El Gayed E J Clin Res Pediatr Endocrinol. 2021; 14(1):76-86.

PMID: 34927407 PMC: 8900082. DOI: 10.4274/jcrpe.galenos.2021.2021.0080.

References

Han B, Shi X, Peng Q, Gao W . Study on Genetic Variance of miR-541 in Type 1 Diabetes. ISRN Endocrinol. 2013; 2012:630861. PMC: 3530230. DOI: 10.5402/2012/630861. View

Grun D, Wang Y, Langenberger D, Gunsalus K, Rajewsky N . microRNA target predictions across seven Drosophila species and comparison to mammalian targets. PLoS Comput Biol. 2005; 1(1):e13. PMC: 1183519. DOI: 10.1371/journal.pcbi.0010013. View

Lakey J, Young A, Pardue D, Calvin S, Albertson T, Jacobson L . Nonviral transfection of intact pancreatic islets. Cell Transplant. 2002; 10(8):697-708. View

Kagami M, OSullivan M, Green A, Watabe Y, Arisaka O, Masawa N . The IG-DMR and the MEG3-DMR at human chromosome 14q32.2: hierarchical interaction and distinct functional properties as imprinting control centers. PLoS Genet. 2010; 6(6):e1000992. PMC: 2887472. DOI: 10.1371/journal.pgen.1000992. View

Seitz H, Royo H, Bortolin M, Lin S, Ferguson-Smith A, Cavaille J . A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res. 2004; 14(9):1741-8. PMC: 515320. DOI: 10.1101/gr.2743304. View

Bravo-Egana V, Rosero S, Klein D, Jiang Z, Vargas N, Tsinoremas N . Inflammation-Mediated Regulation of MicroRNA Expression in Transplanted Pancreatic Islets. J Transplant. 2012; 2012:723614. PMC: 3359768. DOI: 10.1155/2012/723614. View

Joglekar M, Parekh V, Hardikar A . New pancreas from old: microregulators of pancreas regeneration. Trends Endocrinol Metab. 2007; 18(10):393-400. DOI: 10.1016/j.tem.2007.10.001. View

Shemer R, Hershko A, Perk J, Mostoslavsky R, Tsuberi B, Cedar H . The imprinting box of the Prader-Willi/Angelman syndrome domain. Nat Genet. 2000; 26(4):440-3. DOI: 10.1038/82571. View

Ravier M, Rutter G . Isolation and culture of mouse pancreatic islets for ex vivo imaging studies with trappable or recombinant fluorescent probes. Methods Mol Biol. 2010; 633:171-84. DOI: 10.1007/978-1-59745-019-5_12. View

10.

Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, Aravin A . Clustering and conservation patterns of human microRNAs. Nucleic Acids Res. 2005; 33(8):2697-706. PMC: 1110742. DOI: 10.1093/nar/gki567. View

11.

Temple I, Shield J . 6q24 transient neonatal diabetes. Rev Endocr Metab Disord. 2010; 11(3):199-204. DOI: 10.1007/s11154-010-9150-4. View

12.

Caromile L, Oganesian A, Coats S, Seifert R, Bowen-Pope D . The neurosecretory vesicle protein phogrin functions as a phosphatidylinositol phosphatase to regulate insulin secretion. J Biol Chem. 2010; 285(14):10487-96. PMC: 2856256. DOI: 10.1074/jbc.M109.066563. View

13.

Sorenson R, Garry D, Brelje T . Structural and functional considerations of GABA in islets of Langerhans. Beta-cells and nerves. Diabetes. 1991; 40(11):1365-74. DOI: 10.2337/diab.40.11.1365. View

14.

Planas R, Carrillo J, Sanchez A, Ruiz de Villa M, Nunez F, Verdaguer J . Gene expression profiles for the human pancreas and purified islets in type 1 diabetes: new findings at clinical onset and in long-standing diabetes. Clin Exp Immunol. 2009; 159(1):23-44. PMC: 2802692. DOI: 10.1111/j.1365-2249.2009.04053.x. View

15.

Saeki K, Zhu M, Kubosaki A, Xie J, Lan M, Notkins A . Targeted disruption of the protein tyrosine phosphatase-like molecule IA-2 results in alterations in glucose tolerance tests and insulin secretion. Diabetes. 2002; 51(6):1842-50. DOI: 10.2337/diabetes.51.6.1842. View

16.

Tang X, Muniappan L, Tang G, Ozcan S . Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription. RNA. 2008; 15(2):287-93. PMC: 2648717. DOI: 10.1261/rna.1211209. View

17.

Simion A, Laudadio I, Prevot P, Raynaud P, Lemaigre F, Jacquemin P . MiR-495 and miR-218 regulate the expression of the Onecut transcription factors HNF-6 and OC-2. Biochem Biophys Res Commun. 2009; 391(1):293-8. DOI: 10.1016/j.bbrc.2009.11.052. View

18.

Kubosaki A, Nakamura S, Notkins A . Dense core vesicle proteins IA-2 and IA-2beta: metabolic alterations in double knockout mice. Diabetes. 2005; 54 Suppl 2:S46-51. DOI: 10.2337/diabetes.54.suppl_2.s46. View

19.

Wallace C, Smyth D, Maisuria-Armer M, Walker N, Todd J, Clayton D . The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat Genet. 2009; 42(1):68-71. PMC: 2820243. DOI: 10.1038/ng.493. View

20.

Dai Y, Huang Y, Tang M, Lv T, Hu C, Tan Y . Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus. 2007; 16(12):939-46. DOI: 10.1177/0961203307084158. View